These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 7364929

  • 21. Young female patient with testosterone-producing adrenocortical adenoma also showing signs of subclinical Cushing's syndrome.
    Murakami Y, Sasaki M, Sasano H, Suzuki T, Kitamura N, Tomoi M, Yorifuji H, Koshimura K, Kato Y.
    Endocr J; 1995 Apr; 42(2):283-8. PubMed ID: 7627274
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [Abstract] [Full Text] [Related]

  • 23. [Clinical characteristics of Itsenko-Cushing syndrome with various morphological changes in the adrenal cortex].
    Baranov VG, Nechaĭ AI, Trofimov VM, Savushkina AS, Kalashnikov SA.
    Probl Endokrinol (Mosk); 1986 Feb; 32(3):30-4. PubMed ID: 3016700
    [Abstract] [Full Text] [Related]

  • 24. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas.
    Sarkar D, Imai T, Kambe F, Shibata A, Ohmori S, Siddiq A, Hayasaka S, Funahashi H, Seo H.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5130-7. PubMed ID: 11701665
    [Abstract] [Full Text] [Related]

  • 25. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, Grossman A.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [Abstract] [Full Text] [Related]

  • 26. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index.
    van Aken MO, Pereira AM, Frölich M, Romijn JA, Pijl H, Veldhuis JD, Roelfsema F.
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E63-70. PubMed ID: 15328071
    [Abstract] [Full Text] [Related]

  • 27. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland.
    Lamberts SW, Zuiderwijk J, Uitterlinden P, Blijd JJ, Bruining HA, de Jong FH.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930
    [Abstract] [Full Text] [Related]

  • 28. A case of asymptomatic cortisol producing adrenal adenoma.
    Noritake M, Morimoto K, Kosano H, Nemoto Y, Kugai N, Takao M, Murai M, Tamai S, Tanaka K, Nagata N.
    Endocrinol Jpn; 1992 Feb; 39(1):19-24. PubMed ID: 1606918
    [Abstract] [Full Text] [Related]

  • 29. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT, Luria M.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [Abstract] [Full Text] [Related]

  • 30. Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.
    Schteingart DE, Tsao HS.
    J Clin Endocrinol Metab; 1980 May; 50(5):961-6. PubMed ID: 6246139
    [Abstract] [Full Text] [Related]

  • 31. Cushing's syndrome induced by hypersecretion of cortisol from only one of bilateral adrenocortical tumors.
    Kato S, Masunaga R, Kawabe T, Nagasaka A, Miyamoto T, Itoh M, Nakai A, Iwase K, Tsujimura T, Ohtani S.
    Metabolism; 1992 Mar; 41(3):260-3. PubMed ID: 1542264
    [Abstract] [Full Text] [Related]

  • 32. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE, McKenzie AK.
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [Abstract] [Full Text] [Related]

  • 33. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O, Jørgensen H, Frey H, Norman N.
    Tidsskr Nor Laegeforen; 1989 Sep 20; 109(26):2678-82. PubMed ID: 2554527
    [Abstract] [Full Text] [Related]

  • 34. Lack of inhibitory effect of alpha-human atrial natriuretic polypeptide on cortisol secretion in cultured adrenocortical adenoma cells from the patients with Cushing's syndrome.
    Higuchi K, Nawata H, Kato K, Ibayashi H.
    Horm Metab Res; 1988 Jun 20; 20(6):360-3. PubMed ID: 2843450
    [Abstract] [Full Text] [Related]

  • 35. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome.
    Bertagna X, Bertagna C, Laudat MH, Husson JM, Girard F, Luton JP.
    J Clin Endocrinol Metab; 1986 Sep 20; 63(3):639-43. PubMed ID: 3734034
    [Abstract] [Full Text] [Related]

  • 36. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.
    Komanicky P, Spark RF, Melby JC.
    J Clin Endocrinol Metab; 1978 Nov 20; 47(5):1042-51. PubMed ID: 233687
    [Abstract] [Full Text] [Related]

  • 37. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE.
    Expert Opin Emerg Drugs; 2009 Dec 20; 14(4):661-71. PubMed ID: 19939210
    [Abstract] [Full Text] [Related]

  • 38. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF, Hermus AR, Smals AG, Bartelink AK, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1983 Sep 20; 57(3):513-6. PubMed ID: 6308029
    [Abstract] [Full Text] [Related]

  • 39. Studies on lipoprotein and adrenal steroidogenesis: II. Utilization of low density lipoprotein- and high density lipoprotein-cholesterol for steroid production in functioning human adrenocortical adenoma cells in culture.
    Higashijima M, Kato K, Nawata H, Ibayashi H.
    Endocrinol Jpn; 1987 Oct 20; 34(5):647-57. PubMed ID: 3436298
    [Abstract] [Full Text] [Related]

  • 40. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar 20; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.